Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 22 entries
Sorted by: Best Match Show Resources per page
Expertise: No Longer a Sine Qua Non for Guideline Authors?.

Hypertension (Dallas, Tex. : 1979)

Messerli FH, Hofstetter L, Agabiti-Rosei E, Burnier M, Elliott WJ, Franklin SS, Grodzicki T, Kario K, Kjeldsen SE, Kostis JB, Laurent S, Leenen FH, Lund-Johansen P, Mancia G, Narkiewicz K, Papademetriou V, Parati G, Poulter N, Redon J, Rimoldi SF, Ruilope LM, Schiffrin EL, Schmieder RE, Schwartz AB, Sever P, Sowers JR, Staessen JA, Wang J, Weber M, Williams B.
PMID: 28652465
Hypertension. 2017 Aug;70(2):235-237. doi: 10.1161/HYPERTENSIONAHA.117.09470. Epub 2017 Jun 26.

No abstract available.

Cite
Messerli FH, Hofstetter L, Agabiti-Rosei E, et al. Expertise: No Longer a Sine Qua Non for Guideline Authors?. Hypertension. 2017;70(2):235-237doi: 10.1161/HYPERTENSIONAHA.117.09470.
Messerli, F. H., Hofstetter, L., Agabiti-Rosei, E., Burnier, M., Elliott, W. J., Franklin, S. S., Grodzicki, T., Kario, K., Kjeldsen, S. E., Kostis, J. B., Laurent, S., Leenen, F. H., Lund-Johansen, P., Mancia, G., Narkiewicz, K., Papademetriou, V., Parati, G., Poulter, N., Redon, J., Rimoldi, S. F., Ruilope, L. M., Schiffrin, E. L., Schmieder, R. E., Schwartz, A. B., Sever, P., Sowers, J. R., Staessen, J. A., Wang, J., Weber, M., & Williams, B. (2017). Expertise: No Longer a Sine Qua Non for Guideline Authors?. Hypertension (Dallas, Tex. : 1979), 70(2), 235-237. https://doi.org/10.1161/HYPERTENSIONAHA.117.09470
Messerli, Franz H, et al. "Expertise: No Longer a Sine Qua Non for Guideline Authors?." Hypertension (Dallas, Tex. : 1979) vol. 70,2 (2017): 235-237. doi: https://doi.org/10.1161/HYPERTENSIONAHA.117.09470
Messerli FH, Hofstetter L, Agabiti-Rosei E, Burnier M, Elliott WJ, Franklin SS, Grodzicki T, Kario K, Kjeldsen SE, Kostis JB, Laurent S, Leenen FH, Lund-Johansen P, Mancia G, Narkiewicz K, Papademetriou V, Parati G, Poulter N, Redon J, Rimoldi SF, Ruilope LM, Schiffrin EL, Schmieder RE, Schwartz AB, Sever P, Sowers JR, Staessen JA, Wang J, Weber M, Williams B. Expertise: No Longer a Sine Qua Non for Guideline Authors?. Hypertension. 2017 Aug;70(2):235-237. doi: 10.1161/HYPERTENSIONAHA.117.09470. Epub 2017 Jun 26. PMID: 28652465.
Copy Download .nbib Format: NLM
Hypertensive labeling (reply to Dr. Birkenhäger's editorial).

Cardiovascular drugs and therapy

Lund-Johansen P.
PMID: 8241016
Cardiovasc Drugs Ther. 1993 Aug;7(4):727-9. doi: 10.1007/BF00877827.

No abstract available.

Cite
Lund-Johansen P. Hypertensive labeling (reply to Dr. Birkenhäger's editorial). Cardiovasc Drugs Ther. 1993;7(4):727-9doi: 10.1007/BF00877827.
Lund-Johansen, P. (1993). Hypertensive labeling (reply to Dr. Birkenhäger's editorial). Cardiovascular drugs and therapy, 7(4), 727-9. https://doi.org/10.1007/BF00877827
Lund-Johansen, P. "Hypertensive labeling (reply to Dr. Birkenhäger's editorial)." Cardiovascular drugs and therapy vol. 7,4 (1993): 727-9. doi: https://doi.org/10.1007/BF00877827
Lund-Johansen P. Hypertensive labeling (reply to Dr. Birkenhäger's editorial). Cardiovasc Drugs Ther. 1993 Aug;7(4):727-9. doi: 10.1007/BF00877827. PMID: 8241016.
Copy Download .nbib Format: NLM
The SH3PXD2A-HTRA1 fusion transcript is extremely rare in Norwegian sporadic vestibular schwannoma patients.

Journal of neuro-oncology

Taule-Sivertsen P, Bruland O, Håvik AL, Bratland E, Lund-Johansen M, Knappskog PM.
PMID: 34213706
J Neurooncol. 2021 Aug;154(1):35-40. doi: 10.1007/s11060-021-03796-6. Epub 2021 Jul 02.

INTRODUCTION: Vestibular schwannoma (VS) is a benign intracranial tumor in which the underlying genetics is largely uncertain, apart from mutations in the tumor suppressor gene NF2. Alternative tumorigenic mechanisms have been proposed, including a recurrent in-frame fusion transcript of...

Cite
Taule-Sivertsen P, Bruland O, Håvik AL, et al. The SH3PXD2A-HTRA1 fusion transcript is extremely rare in Norwegian sporadic vestibular schwannoma patients. J Neurooncol. 2021;154(1):35-40doi: 10.1007/s11060-021-03796-6.
Taule-Sivertsen, P., Bruland, O., Håvik, A. L., Bratland, E., Lund-Johansen, M., & Knappskog, P. M. (2021). The SH3PXD2A-HTRA1 fusion transcript is extremely rare in Norwegian sporadic vestibular schwannoma patients. Journal of neuro-oncology, 154(1), 35-40. https://doi.org/10.1007/s11060-021-03796-6
Taule-Sivertsen, Peter, et al. "The SH3PXD2A-HTRA1 fusion transcript is extremely rare in Norwegian sporadic vestibular schwannoma patients." Journal of neuro-oncology vol. 154,1 (2021): 35-40. doi: https://doi.org/10.1007/s11060-021-03796-6
Taule-Sivertsen P, Bruland O, Håvik AL, Bratland E, Lund-Johansen M, Knappskog PM. The SH3PXD2A-HTRA1 fusion transcript is extremely rare in Norwegian sporadic vestibular schwannoma patients. J Neurooncol. 2021 Aug;154(1):35-40. doi: 10.1007/s11060-021-03796-6. Epub 2021 Jul 02. PMID: 34213706; PMCID: PMC8367919.
Copy Download .nbib Format: NLM
Genetic alterations associated with malignant transformation of sporadic vestibular schwannoma.

Acta neurochirurgica

Håvik AL, Bruland O, Miletic H, Poulsgaard L, Scheie D, Fugleholm K, Lund-Johansen M, Knappskog PM.
PMID: 34816314
Acta Neurochir (Wien). 2021 Nov 24; doi: 10.1007/s00701-021-05062-0. Epub 2021 Nov 24.

INTRODUCTION: Malignant peripheral nerve sheath tumor of the vestibulocochlear nerve (VN-MPNST) is exceedingly rare and carries a poor prognosis. Little is known about its underlying genetics and in particular the process of malignant transformation. There is an ongoing debate...

Cite
Håvik AL, Bruland O, Miletic H, et al. Genetic alterations associated with malignant transformation of sporadic vestibular schwannoma. Acta Neurochir (Wien). 2021;doi: 10.1007/s00701-021-05062-0.
Håvik, A. L., Bruland, O., Miletic, H., Poulsgaard, L., Scheie, D., Fugleholm, K., Lund-Johansen, M., & Knappskog, P. M. (2021). Genetic alterations associated with malignant transformation of sporadic vestibular schwannoma. Acta neurochirurgica, . https://doi.org/10.1007/s00701-021-05062-0
Håvik, Aril Løge, et al. "Genetic alterations associated with malignant transformation of sporadic vestibular schwannoma." Acta neurochirurgica vol. (2021). doi: https://doi.org/10.1007/s00701-021-05062-0
Håvik AL, Bruland O, Miletic H, Poulsgaard L, Scheie D, Fugleholm K, Lund-Johansen M, Knappskog PM. Genetic alterations associated with malignant transformation of sporadic vestibular schwannoma. Acta Neurochir (Wien). 2021 Nov 24; doi: 10.1007/s00701-021-05062-0. Epub 2021 Nov 24. PMID: 34816314.
Copy Download .nbib Format: NLM
A compact vocabulary of paratope-epitope interactions enables predictability of antibody-antigen binding.

Cell reports

Akbar R, Robert PA, Pavlović M, Jeliazkov JR, Snapkov I, Slabodkin A, Weber CR, Scheffer L, Miho E, Haff IH, Haug DTT, Lund-Johansen F, Safonova Y, Sandve GK, Greiff V.
PMID: 33730590
Cell Rep. 2021 Mar 16;34(11):108856. doi: 10.1016/j.celrep.2021.108856.

Antibody-antigen binding relies on the specific interaction of amino acids at the paratope-epitope interface. The predictability of antibody-antigen binding is a prerequisite for de novo antibody and (neo-)epitope design. A fundamental premise for the predictability of antibody-antigen binding is...

Cite
Akbar R, Robert PA, Pavlović M, et al. A compact vocabulary of paratope-epitope interactions enables predictability of antibody-antigen binding. Cell Rep. 2021;34(11):108856doi: 10.1016/j.celrep.2021.108856.
Akbar, R., Robert, P. A., Pavlović, M., Jeliazkov, J. R., Snapkov, I., Slabodkin, A., Weber, C. R., Scheffer, L., Miho, E., Haff, I. H., Haug, D. T. T., Lund-Johansen, F., Safonova, Y., Sandve, G. K., & Greiff, V. (2021). A compact vocabulary of paratope-epitope interactions enables predictability of antibody-antigen binding. Cell reports, 34(11), 108856. https://doi.org/10.1016/j.celrep.2021.108856
Akbar, Rahmad, et al. "A compact vocabulary of paratope-epitope interactions enables predictability of antibody-antigen binding." Cell reports vol. 34,11 (2021): 108856. doi: https://doi.org/10.1016/j.celrep.2021.108856
Akbar R, Robert PA, Pavlović M, Jeliazkov JR, Snapkov I, Slabodkin A, Weber CR, Scheffer L, Miho E, Haff IH, Haug DTT, Lund-Johansen F, Safonova Y, Sandve GK, Greiff V. A compact vocabulary of paratope-epitope interactions enables predictability of antibody-antigen binding. Cell Rep. 2021 Mar 16;34(11):108856. doi: 10.1016/j.celrep.2021.108856. PMID: 33730590.
Copy Download .nbib Format: NLM
Humoral and cellular immune responses to two and three doses of SARS-CoV-2 vaccines in rituximab-treated patients with rheumatoid arthritis: a prospective, cohort study.

The Lancet. Rheumatology

Jyssum I, Kared H, Tran TT, Tveter AT, Provan SA, Sexton J, Jørgensen KK, Jahnsen J, Kro GB, Warren DJ, Vaage EB, Kvien TK, Nissen-Meyer LH, Anderson AM, Grødeland G, Haavardsholm EA, Vaage JT, Mjaaland S, Syversen SW, Lund-Johansen F, Munthe LA, Goll GL.
PMID: 34977602
Lancet Rheumatol. 2021 Dec 23; doi: 10.1016/S2665-9913(21)00394-5. Epub 2021 Dec 23.

BACKGROUND: In rituximab-treated patients with rheumatoid arthritis, humoral and cellular immune responses after two or three doses of SARS-CoV-2 vaccines are not well characterised. We aimed to address this knowledge gap.METHODS: This prospective, cohort study (Nor-vaC) was done at...

Cite
Jyssum I, Kared H, Tran TT, et al. Humoral and cellular immune responses to two and three doses of SARS-CoV-2 vaccines in rituximab-treated patients with rheumatoid arthritis: a prospective, cohort study. Lancet Rheumatol. 2021;doi: 10.1016/S2665-9913(21)00394-5.
Jyssum, I., Kared, H., Tran, T. T., Tveter, A. T., Provan, S. A., Sexton, J., Jørgensen, K. K., Jahnsen, J., Kro, G. B., Warren, D. J., Vaage, E. B., Kvien, T. K., Nissen-Meyer, L. H., Anderson, A. M., Grødeland, G., Haavardsholm, E. A., Vaage, J. T., Mjaaland, S., Syversen, S. W., Lund-Johansen, F., Munthe, L. A., & Goll, G. L. (2021). Humoral and cellular immune responses to two and three doses of SARS-CoV-2 vaccines in rituximab-treated patients with rheumatoid arthritis: a prospective, cohort study. The Lancet. Rheumatology, . https://doi.org/10.1016/S2665-9913(21)00394-5
Jyssum, Ingrid, et al. "Humoral and cellular immune responses to two and three doses of SARS-CoV-2 vaccines in rituximab-treated patients with rheumatoid arthritis: a prospective, cohort study." The Lancet. Rheumatology vol. (2021). doi: https://doi.org/10.1016/S2665-9913(21)00394-5
Jyssum I, Kared H, Tran TT, Tveter AT, Provan SA, Sexton J, Jørgensen KK, Jahnsen J, Kro GB, Warren DJ, Vaage EB, Kvien TK, Nissen-Meyer LH, Anderson AM, Grødeland G, Haavardsholm EA, Vaage JT, Mjaaland S, Syversen SW, Lund-Johansen F, Munthe LA, Goll GL. Humoral and cellular immune responses to two and three doses of SARS-CoV-2 vaccines in rituximab-treated patients with rheumatoid arthritis: a prospective, cohort study. Lancet Rheumatol. 2021 Dec 23; doi: 10.1016/S2665-9913(21)00394-5. Epub 2021 Dec 23. PMID: 34977602; PMCID: PMC8700278.
Copy Download .nbib Format: NLM
Reply.

Journal of hypertension

Messerli FH, Hofstetter L, Agabiti-Rosei E, Burnier M, Elliott WJ, Franklin SS, Grodzicki T, Kario K, Kjeldsen SE, Kostis JB, Laurent S, Leenen FH, de Leeuw PW, Lund-Johansen P, Mancia G, Narkiewicz K, Papademetriou V, Parati G, Poulter N, Redon J, Rimoldi SF, Ruilope LM, Schiffrin EL, Schmieder RE, Schwartz AB, Sever P, Sowers JR, Staessen JA, Wang J, Weber M, Williams B.
PMID: 28953595
J Hypertens. 2017 Nov;35(11):2327-2328. doi: 10.1097/HJH.0000000000001526.

No abstract available.

Cite
Messerli FH, Hofstetter L, Agabiti-Rosei E, et al. Reply. J Hypertens. 2017;35(11):2327-2328doi: 10.1097/HJH.0000000000001526.
Messerli, F. H., Hofstetter, L., Agabiti-Rosei, E., Burnier, M., Elliott, W. J., Franklin, S. S., Grodzicki, T., Kario, K., Kjeldsen, S. E., Kostis, J. B., Laurent, S., Leenen, F. H., de Leeuw, P. W., Lund-Johansen, P., Mancia, G., Narkiewicz, K., Papademetriou, V., Parati, G., Poulter, N., Redon, J., Rimoldi, S. F., Ruilope, L. M., Schiffrin, E. L., Schmieder, R. E., Schwartz, A. B., Sever, P., Sowers, J. R., Staessen, J. A., Wang, J., Weber, M., & Williams, B. (2017). Reply. Journal of hypertension, 35(11), 2327-2328. https://doi.org/10.1097/HJH.0000000000001526
Messerli, Franz H, et al. "Reply." Journal of hypertension vol. 35,11 (2017): 2327-2328. doi: https://doi.org/10.1097/HJH.0000000000001526
Messerli FH, Hofstetter L, Agabiti-Rosei E, Burnier M, Elliott WJ, Franklin SS, Grodzicki T, Kario K, Kjeldsen SE, Kostis JB, Laurent S, Leenen FH, de Leeuw PW, Lund-Johansen P, Mancia G, Narkiewicz K, Papademetriou V, Parati G, Poulter N, Redon J, Rimoldi SF, Ruilope LM, Schiffrin EL, Schmieder RE, Schwartz AB, Sever P, Sowers JR, Staessen JA, Wang J, Weber M, Williams B. Reply. J Hypertens. 2017 Nov;35(11):2327-2328. doi: 10.1097/HJH.0000000000001526. PMID: 28953595.
Copy Download .nbib Format: NLM
Spatial-proteomics reveals phospho-signaling dynamics at subcellular resolution.

Nature communications

Martinez-Val A, Bekker-Jensen DB, Steigerwald S, Koenig C, Østergaard O, Mehta A, Tran T, Sikorski K, Torres-Vega E, Kwasniewicz E, Brynjólfsdóttir SH, Frankel LB, Kjøbsted R, Krogh N, Lundby A, Bekker-Jensen S, Lund-Johansen F, Olsen JV.
PMID: 34876567
Nat Commun. 2021 Dec 07;12(1):7113. doi: 10.1038/s41467-021-27398-y.

Dynamic change in subcellular localization of signaling proteins is a general concept that eukaryotic cells evolved for eliciting a coordinated response to stimuli. Mass spectrometry-based proteomics in combination with subcellular fractionation can provide comprehensive maps of spatio-temporal regulation of...

Cite
Martinez-Val A, Bekker-Jensen DB, Steigerwald S, et al. Spatial-proteomics reveals phospho-signaling dynamics at subcellular resolution. Nat Commun. 2021;12(1):7113doi: 10.1038/s41467-021-27398-y.
Martinez-Val, A., Bekker-Jensen, D. B., Steigerwald, S., Koenig, C., Østergaard, O., Mehta, A., Tran, T., Sikorski, K., Torres-Vega, E., Kwasniewicz, E., Brynjólfsdóttir, S. H., Frankel, L. B., Kjøbsted, R., Krogh, N., Lundby, A., Bekker-Jensen, S., Lund-Johansen, F., & Olsen, J. V. (2021). Spatial-proteomics reveals phospho-signaling dynamics at subcellular resolution. Nature communications, 12(1), 7113. https://doi.org/10.1038/s41467-021-27398-y
Martinez-Val, Ana, et al. "Spatial-proteomics reveals phospho-signaling dynamics at subcellular resolution." Nature communications vol. 12,1 (2021): 7113. doi: https://doi.org/10.1038/s41467-021-27398-y
Martinez-Val A, Bekker-Jensen DB, Steigerwald S, Koenig C, Østergaard O, Mehta A, Tran T, Sikorski K, Torres-Vega E, Kwasniewicz E, Brynjólfsdóttir SH, Frankel LB, Kjøbsted R, Krogh N, Lundby A, Bekker-Jensen S, Lund-Johansen F, Olsen JV. Spatial-proteomics reveals phospho-signaling dynamics at subcellular resolution. Nat Commun. 2021 Dec 07;12(1):7113. doi: 10.1038/s41467-021-27398-y. PMID: 34876567; PMCID: PMC8651693.
Copy Download .nbib Format: NLM
Spatial-proteomics reveals phospho-signaling dynamics at subcellular resolution.

Nature communications

Martinez-Val A, Bekker-Jensen DB, Steigerwald S, Koenig C, Østergaard O, Mehta A, Tran T, Sikorski K, Torres-Vega E, Kwasniewicz E, Brynjólfsdóttir SH, Frankel LB, Kjøbsted R, Krogh N, Lundby A, Bekker-Jensen S, Lund-Johansen F, Olsen JV.
PMID: 34876567
Nat Commun. 2021 Dec 07;12(1):7113. doi: 10.1038/s41467-021-27398-y.

Dynamic change in subcellular localization of signaling proteins is a general concept that eukaryotic cells evolved for eliciting a coordinated response to stimuli. Mass spectrometry-based proteomics in combination with subcellular fractionation can provide comprehensive maps of spatio-temporal regulation of...

Cite
Martinez-Val A, Bekker-Jensen DB, Steigerwald S, et al. Spatial-proteomics reveals phospho-signaling dynamics at subcellular resolution. Nat Commun. 2021;12(1):7113doi: 10.1038/s41467-021-27398-y.
Martinez-Val, A., Bekker-Jensen, D. B., Steigerwald, S., Koenig, C., Østergaard, O., Mehta, A., Tran, T., Sikorski, K., Torres-Vega, E., Kwasniewicz, E., Brynjólfsdóttir, S. H., Frankel, L. B., Kjøbsted, R., Krogh, N., Lundby, A., Bekker-Jensen, S., Lund-Johansen, F., & Olsen, J. V. (2021). Spatial-proteomics reveals phospho-signaling dynamics at subcellular resolution. Nature communications, 12(1), 7113. https://doi.org/10.1038/s41467-021-27398-y
Martinez-Val, Ana, et al. "Spatial-proteomics reveals phospho-signaling dynamics at subcellular resolution." Nature communications vol. 12,1 (2021): 7113. doi: https://doi.org/10.1038/s41467-021-27398-y
Martinez-Val A, Bekker-Jensen DB, Steigerwald S, Koenig C, Østergaard O, Mehta A, Tran T, Sikorski K, Torres-Vega E, Kwasniewicz E, Brynjólfsdóttir SH, Frankel LB, Kjøbsted R, Krogh N, Lundby A, Bekker-Jensen S, Lund-Johansen F, Olsen JV. Spatial-proteomics reveals phospho-signaling dynamics at subcellular resolution. Nat Commun. 2021 Dec 07;12(1):7113. doi: 10.1038/s41467-021-27398-y. PMID: 34876567.
Copy Download .nbib Format: NLM
Trends in seroprevalence of SARS-CoV-2 and infection fatality rate in the Norwegian population through the first year of the COVID-19 pandemic.

Influenza and other respiratory viruses

Tunheim G, Rø GØI, Tran T, Kran AB, Andersen JT, Vaage EB, Kolderup A, Vaage JT, Lund-Johansen F, Hungnes O.
PMID: 34751488
Influenza Other Respir Viruses. 2021 Nov 09; doi: 10.1111/irv.12932. Epub 2021 Nov 09.

BACKGROUND: Infection with the novel coronavirus SARS-CoV-2 induces antibodies that can be used as a proxy for COVID-19. We present a repeated nationwide cross-sectional study assessing the seroprevalence of SARS-CoV-2, the infection fatality rate (IFR), and infection hospitalization rate...

Cite
Tunheim G, Rø GØI, Tran T, et al. Trends in seroprevalence of SARS-CoV-2 and infection fatality rate in the Norwegian population through the first year of the COVID-19 pandemic. Influenza Other Respir Viruses. 2021;doi: 10.1111/irv.12932.
Tunheim, G., Rø, G. �. �. I., Tran, T., Kran, A. B., Andersen, J. T., Vaage, E. B., Kolderup, A., Vaage, J. T., Lund-Johansen, F., & Hungnes, O. (2021). Trends in seroprevalence of SARS-CoV-2 and infection fatality rate in the Norwegian population through the first year of the COVID-19 pandemic. Influenza and other respiratory viruses, . https://doi.org/10.1111/irv.12932
Tunheim, Gro, et al. "Trends in seroprevalence of SARS-CoV-2 and infection fatality rate in the Norwegian population through the first year of the COVID-19 pandemic." Influenza and other respiratory viruses vol. (2021). doi: https://doi.org/10.1111/irv.12932
Tunheim G, Rø GØI, Tran T, Kran AB, Andersen JT, Vaage EB, Kolderup A, Vaage JT, Lund-Johansen F, Hungnes O. Trends in seroprevalence of SARS-CoV-2 and infection fatality rate in the Norwegian population through the first year of the COVID-19 pandemic. Influenza Other Respir Viruses. 2021 Nov 09; doi: 10.1111/irv.12932. Epub 2021 Nov 09. PMID: 34751488; PMCID: PMC8652705.
Copy Download .nbib Format: NLM
Persistent pulmonary pathology after COVID-19 is associated with high viral load, weak antibody response, and high levels of matrix metalloproteinase-9.

Scientific reports

Lerum TV, Maltzahn NN, Aukrust P, Trøseid M, Henriksen KN, Kåsine T, Dyrhol-Riise AM, Stiksrud B, Haugli M, Blomberg B, Kittang BR, Johannessen A, Hannula R, Aballi S, Kildal AB, Eiken R, Dahl TB, Lund-Johansen F, Müller F, Rodriguez JR, Meltzer C, Einvik G, Ueland T, Olsen IC, Barratt-Due A, Aaløkken TM, Skjønsberg OH.
PMID: 34853380
Sci Rep. 2021 Dec 01;11(1):23205. doi: 10.1038/s41598-021-02547-x.

The association between pulmonary sequelae and markers of disease severity, as well as pro-fibrotic mediators, were studied in 108 patients 3 months after hospital admission for COVID-19. The COPD assessment test (CAT-score), spirometry, diffusion capacity of the lungs (DL

Cite
Lerum TV, Maltzahn NN, Aukrust P, et al. Persistent pulmonary pathology after COVID-19 is associated with high viral load, weak antibody response, and high levels of matrix metalloproteinase-9. Sci Rep. 2021;11(1):23205doi: 10.1038/s41598-021-02547-x.
Lerum, T. V., Maltzahn, N. N., Aukrust, P., Trøseid, M., Henriksen, K. N., Kåsine, T., Dyrhol-Riise, A. M., Stiksrud, B., Haugli, M., Blomberg, B., Kittang, B. R., Johannessen, A., Hannula, R., Aballi, S., Kildal, A. B., Eiken, R., Dahl, T. B., Lund-Johansen, F., Müller, F., Rodriguez, J. R., Meltzer, C., Einvik, G., Ueland, T., Olsen, I. C., Barratt-Due, A., Aaløkken, T. M., & Skjønsberg, O. H. (2021). Persistent pulmonary pathology after COVID-19 is associated with high viral load, weak antibody response, and high levels of matrix metalloproteinase-9. Scientific reports, 11(1), 23205. https://doi.org/10.1038/s41598-021-02547-x
Lerum, Tøri Vigeland, et al. "Persistent pulmonary pathology after COVID-19 is associated with high viral load, weak antibody response, and high levels of matrix metalloproteinase-9." Scientific reports vol. 11,1 (2021): 23205. doi: https://doi.org/10.1038/s41598-021-02547-x
Lerum TV, Maltzahn NN, Aukrust P, Trøseid M, Henriksen KN, Kåsine T, Dyrhol-Riise AM, Stiksrud B, Haugli M, Blomberg B, Kittang BR, Johannessen A, Hannula R, Aballi S, Kildal AB, Eiken R, Dahl TB, Lund-Johansen F, Müller F, Rodriguez JR, Meltzer C, Einvik G, Ueland T, Olsen IC, Barratt-Due A, Aaløkken TM, Skjønsberg OH. Persistent pulmonary pathology after COVID-19 is associated with high viral load, weak antibody response, and high levels of matrix metalloproteinase-9. Sci Rep. 2021 Dec 01;11(1):23205. doi: 10.1038/s41598-021-02547-x. PMID: 34853380; PMCID: PMC8636497.
Copy Download .nbib Format: NLM
A prospective study of the natural history of incidental meningioma-Hold your horses!.

Neuro-oncology practice

Behbahani M, Skeie GO, Eide GE, Hausken A, Lund-Johansen M, Skeie BS.
PMID: 31832214
Neurooncol Pract. 2019 Dec;6(6):438-450. doi: 10.1093/nop/npz011. Epub 2019 Apr 17.

BACKGROUND: The number of incidental meningiomas has increased because of the increased availability of neuroimaging. Lack of prospective data on the natural history makes the optimal management unclear. We conducted a 5-year prospective study of incidental meningiomas to identify...

Cite
Behbahani M, Skeie GO, Eide GE, et al. A prospective study of the natural history of incidental meningioma-Hold your horses!. Neurooncol Pract. 2019;6(6):438-450doi: 10.1093/nop/npz011.
Behbahani, M., Skeie, G. O., Eide, G. E., Hausken, A., Lund-Johansen, M., & Skeie, B. S. (2019). A prospective study of the natural history of incidental meningioma-Hold your horses!. Neuro-oncology practice, 6(6), 438-450. https://doi.org/10.1093/nop/npz011
Behbahani, Maziar, et al. "A prospective study of the natural history of incidental meningioma-Hold your horses!." Neuro-oncology practice vol. 6,6 (2019): 438-450. doi: https://doi.org/10.1093/nop/npz011
Behbahani M, Skeie GO, Eide GE, Hausken A, Lund-Johansen M, Skeie BS. A prospective study of the natural history of incidental meningioma-Hold your horses!. Neurooncol Pract. 2019 Dec;6(6):438-450. doi: 10.1093/nop/npz011. Epub 2019 Apr 17. PMID: 31832214; PMCID: PMC6899048.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 22 entries